Medtronic Buys Chinese Medical Device Maker; Four Healthcare Companies Rated Best Investments; Aurobindo Pharma Gets Tentative FDA OK for Diabetes Tablets - Health Minute for October 4, 2012

Primary tabs

Medtronic Buys Chinese Medical Device Maker; Four Healthcare Companies Rated Best Investments; Aurobindo Pharma Gets Tentative FDA OK for Diabetes Tablets - Health Minute for October 4, 2012

tweet me:
.@Medtronic Buys Chinese Medical Device Maker; 4 Healthcare Best Buys; Aurobindo Gets Tentative FDA OK on Diabetes Tabs http://3bl.me/6xvstk

Multimedia from this Release

Thursday, October 4, 2012 - 12:30pm

CONTENT: Press Release

Medtronic has acquired China Kanghui, the medical device maker, for $816 million. The purchase increases Medtronic’s presence in China for its portfolio of medical devices, which ranges from pacemakers and stents to spinal implants and surgical instruments. 

Healthcare companies in four different categories have been favored recently by investment analysts, due to high-liquid cash positions that allow them to fund research and development strategies. They are Horizon Pharma, a biopharmaceutical company that develops medicines for the treatment of inflammatory diseases; Derma Sciences, a medical technology company; Trinity Biotech, which manufactures and sells self-diagnostic test kits; and Nanosphere, maker and marketer of the Verigene System that enables genomic and protein testing on a single platform.

Aurobindo Pharma has received tentative approval from the FDA for its antidiabetic tablets. The new tablets are the generic equivalent of Actoplus Met Tablets. They are indicated as an adjunct to diet and exercise to improve glycemic control in adults with tye-2 diabetes.

For more information on these and other stories, go to 3blmedia.com

Video Source: Medtronic Buys Chinese Medical Device Maker; Four Healthcare Companies Rated as Best Investments; Aurobindo Pharma Gets Tentative FDA OK for Diabetes Tablets

Keywords: 3bl Media | Pharma News, Research & Solutions | Aurobindo Pharma | China | China Kanghui | Derma Sciences | Health | Horizon Pharma | Medtronic | Nanosphere | Research and development strategies

CONTENT: Press Release

parse.ly